EYPT - Company ID 0001314102
EyePoint Pharmaceuticals, Inc. (EYPT) reported revenue of $31.37M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $31.37M | -27.5% |
| FY 2024 | $43.27M | -6.0% |
| FY 2023 | $46.02M | +11.1% |
| FY 2022 | $41.40M | +12.1% |
| FY 2021 | $36.94M | +7.3% |
| FY 2020 | $34.44M | +69.1% |
| FY 2019 | $20.36M | +345.5% |
| FY 2018 | $4.57M | -39.4% |
| FY 2017 |
EyePoint Pharmaceuticals, Inc. (EYPT) reported revenue of $31.37M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, EyePoint Pharmaceuticals, Inc.'s revenue grew from $4.96M to $31.37M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $7.54M |
| +365.4% |
| FY 2016 | $1.62M | -93.9% |
| FY 2015 | $26.57M | +664.9% |
| FY 2014 | $3.47M | +62.1% |
| FY 2013 | $2.14M | -39.2% |
| FY 2012 | $3.53M | -29.0% |
| FY 2011 | $4.96M | - |